Mesenchymal stem cells derived exosomal miR-323-3p promotes proliferation and inhibits apoptosis of cumulus cells in polycystic ovary syndrome (PCOS)
Source abstract
Abstract
Polycystic ovary syndrome (PCOS) is a heterogeneous reproductive disease. Adipose mesenchymal stem cells (AMSCs) can produce a mass of exosomes. The objective of this study was to determine the effects of exosomal miR-323-3p on cumulus cells (CCs) of PCOS patients. Exosomal miR-323-3p were collected from modified AMSCs. Real-time PCR, western blots, MTT assays, flow cytometry, luciferase reporter assays and a letrozole-induced PCOS mouse model were used to identify mechanisms of exosomal miR-323-3p on CCs. The results revealed that miR-323-3p expression was upregulated in AMSCs, exosomes and CCs. Upregulated miR-323-3p promoted cell proliferation and suppressed apoptosis in CCs, while miR-323-3p inhibitor exerted opposite roles in exosome-treated CCs. Moreover, PDCD4 was upregulated in PCOS CCs, displayed an inverse expression pattern to those of miR-323-3p, and was a direct target of miR-323-3p. Overexpression of PDCD4 reversed the effects of upregulated miR-323-3p on CCs. Serum FSH, LH and testosterone were upregulated while E2 levels were downregulated in the PCOS mice. Upregulation of miR-323-3p alleviated PCOS by suppressing CCs’ apoptosis through targeting PDCD4 in vivo. The results demonstrated that exosomal miR-323-3p promoted cell proliferation and inhibited apoptosis in CCs through targeting PDCD4 in PCOS. This study provides insight into developing new therapeutic strategies for PCOS.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Ovarian function and disorders · Reproductive Biology and Fertility · Reproductive System and Pregnancy
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Gynecology Department, Jinan City People Hospital
References (46)
Show source-provided references
1. 10.1038/nrdp.2016.5710.1038/nrdp.2016.57 ↗
2. 10.2174/13816121280330759010.2174/138161212803307590 ↗
3. 10.1210/er.2011-103410.1210/er.2011-1034 ↗
4. 10.1210/jc.2005-149410.1210/jc.2005-1494 ↗
5. 10.1210/jc.2005-062810.1210/jc.2005-0628 ↗
6. 10.1111/j.1365-2265.2010.03956.x10.1111/j.1365-2265.2010.03956.x ↗
7. 10.1210/jc.2007-165010.1210/jc.2007-1650 ↗
8. 10.1093/humupd/dmm04010.1093/humupd/dmm040 ↗
9. 10.1007/s00404-017-4523-510.1007/s00404-017-4523-5 ↗
10. 10.1093/molehr/7.4.32510.1093/molehr/7.4.325 ↗
11. 10.1038/nrg245510.1038/nrg2455 ↗
12. 10.1002/jcp.2199910.1002/jcp.21999 ↗
13. 10.1210/jc.2013-171510.1210/jc.2013-1715 ↗
14. 10.1016/j.rbmo.2015.06.02310.1016/j.rbmo.2015.06.023 ↗
15. 10.4161/cib.3.5.1233910.4161/cib.3.5.12339 ↗
16. 10.1073/pnas.091484310710.1073/pnas.0914843107 ↗
17. 10.1186/s13045-015-0181-x10.1186/s13045-015-0181-x ↗
18. 10.2174/15665231280208359410.2174/156652312802083594 ↗
19. 10.1016/j.addr.2012.07.00110.1016/j.addr.2012.07.001 ↗
20. 10.1002/stem.112910.1002/stem.1129 ↗
21. 10.1111/jcmm.1317010.1111/jcmm.13170 ↗
22. 10.1186/s13045-015-0220-710.1186/s13045-015-0220-7 ↗
23. 10.1373/clinchem.2011.17928310.1373/clinchem.2011.179283 ↗
24. 10.1007/s00296-013-2767-310.1007/s00296-013-2767-3 ↗
25. 10.1016/j.gene.2018.10.00610.1016/j.gene.2018.10.006 ↗
26. 10.1016/j.fertnstert.2003.10.00410.1016/j.fertnstert.2003.10.004 ↗
27. 10.1089/scd.2006.011810.1089/scd.2006.0118 ↗
28. 10.1016/j.diff.2013.02.00110.1016/j.diff.2013.02.001 ↗
29. 10.18632/oncotarget.2473710.18632/oncotarget.24737 ↗
30. 10.1007/s00109-008-0403-610.1007/s00109-008-0403-6 ↗
31. 10.1038/celldisc.2017.2210.1038/celldisc.2017.22 ↗
32. 10.1371/journal.pone.014650910.1371/journal.pone.0146509 ↗
33. 10.1056/NEJMra04153610.1056/NEJMra041536 ↗
34. 10.1016/S0140-6736(07)61345-210.1016/S0140-6736(07)61345-2 ↗
35. 10.1016/j.gene.2014.08.04110.1016/j.gene.2014.08.041 ↗
36. 10.1038/mt.2016.9010.1038/mt.2016.90 ↗
37. 10.1002/stem.256410.1002/stem.2564 ↗
38. 10.2147/OTT.S14331510.2147/OTT.S143315 ↗
39. 10.1517/14728222.2014.85520110.1517/14728222.2014.855201 ↗
40. 10.1038/srep0868910.1038/srep08689 ↗
41. 10.1373/clinchem.2010.14766010.1373/clinchem.2010.147660 ↗
42. 10.1016/j.biolcel.2003.09.00310.1016/j.biolcel.2003.09.003 ↗
43. 10.1128/MCB.24.9.3894-3906.200410.1128/MCB.24.9.3894-3906.2004 ↗
44. 10.1002/(SICI)1098-2795(199811)51:3<243::AID-MRD3>3.0.CO;2-P10.1002/(SICI)1098-2795(199811)51:3<243::AID-MRD3>3.0.CO;2-P ↗
45. 10.1016/j.fertnstert.2016.01.02010.1016/j.fertnstert.2016.01.020 ↗
46. 10.1093/humrep/15.9.188910.1093/humrep/15.9.1889 ↗